Aclaris Therapeutics, Inc. Restructuring Charges
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2025-02-27
- Aclaris Therapeutics, Inc. restructuring charges for the quarter ending 2024-09-30 was $32.00K.
- Aclaris Therapeutics, Inc. restructuring charges for the quarter ending 2024-06-30 was $98.00K.
- Aclaris Therapeutics, Inc. restructuring charges for the quarter ending 2024-03-31 was $2.53M.
- Aclaris Therapeutics, Inc. restructuring charges for fiscal 2023 was $3.10M.
| Period end | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month | Restructuring Charges 12 month as first filed |
|---|---|---|---|---|---|
| 2024-09-30 | $32.00K 10-Q · filed 2024-11-06 | $130.00K derived: sum of 2 quarters · filed 2024-11-06 | $2.90M 10-Q · filed 2024-11-06 | ||
| 2024-06-30 | $98.00K 10-Q · filed 2024-08-07 | $2.87M 10-Q · filed 2024-08-07 | |||
| 2024-03-31 | $2.53M 10-Q · filed 2024-05-07 | ||||
| 2023-12-31 | $3.10M 10-K · filed 2025-02-27 | $3.13M 10-K · filed 2024-02-27 |